| This article has been cited by |
| 1 | Management of severe arterial hypertension associated with serotonin syndrome: a case report analysis based on systematic review techniques | |
| Michael Ott,Julie K. Mannchen,Fariba Jamshidi,Ursula Werneke |
| Therapeutic Advances in Psychopharmacology.2019;9()204512531881881 |
| [DOI] |
|
| 2 | Management of severe arterial hypertension associated with serotonin syndrome: a case report analysis based on systematic review techniques | |
| Eoin Mulroy,Kailash P. Bhatia |
| Therapeutic Advances in Psychopharmacology.2022;9()241 |
| [DOI] |
|
| 3 | Serotonin syndrome caused by drug to drug interaction between escitalopram and dextromethorphan | |
| Prudence Dy,Victor Arcega,Wael Ghali,Winifred Wolfe |
| BMJ Case Reports.2017;9()bcr-2017-221486 |
| [DOI] |
|
| 4 | A Case of Serotonin Syndrome Due to Amantadine and Escitalopram in End-Stage Renal Disease | |
| Jun Seok Choi,Eun Kyoung Lee |
| Korean Journal of Medicine.2012;83(1)122 |
| [DOI] |
|
| 5 | Pharmacologic Safety Concerns in Parkinson's Disease: Facts and Insights | |
| Jack J. Chen |
| International Journal of Neuroscience.2011;121(sup2)45 |
| [DOI] |
|
